Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

被引:1
|
作者
Wu Xiao-long [1 ]
Zhuang Hai-feng [1 ]
Zhao Yan-na [1 ]
Yu Xiao-ling [1 ]
Dai Tie-ying [1 ]
Gao Rui-lan [1 ]
机构
[1] Zhejiang Chinese Med Univ, Inst Hematol Res, Affiliated Hosp 1, Hangzhou 310006, Peoples R China
基金
中国国家自然科学基金;
关键词
Chinese medicine; hematopoietic stem cell transplantation; graft-versus-host disease; CD4(+) T-CELLS; GVHD; MICE;
D O I
10.1007/s11655-020-3252-y
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Graft-versus-host disease (GVHD) is the most common complication after allogeneic hematopoietic stem cell transplantation, and also an important factor affecting the survival and quality of life in patients after transplantation. Currently, immunosuppressive therapy is commonly used for GVHD, but the curative effect is not ideal. How to effectively prevent and treat GVHD is one of the difficulties to be solved urgently in the field of transplantation. In this paper, we summarize the latest progress in pathogenesis, prevention and treatment of GVHD with Chinese medicine (CM). We hope it will provide ideas and methods for exploring the mechanism and establishing a new comprehensive therapy for GVHD with CM.
引用
收藏
页码:324 / 329
页数:6
相关论文
共 50 条
  • [21] TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Zhao, Yi
    Liu, Qiuyan
    Yang, Li
    He, Donghua
    Wang, Lijuan
    Tian, Jun
    Li, Yi
    Zi, Fuming
    Bao, Hanying
    Yang, Yang
    Zheng, Yuanyuan
    Shi, Jimin
    Xue, Xingkui
    Cai, Zhen
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (02) : 165 - 175
  • [22] Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease
    Gebremedhin, Efrem
    Behrendt, Carolyn E.
    Nakamura, Ryotaro
    Parker, Pablo
    Salehian, Behrouz
    INFLAMMATION, 2013, 36 (01) : 177 - 185
  • [23] Graft-Versus-Host Disease Sustains Coagulation Activity for two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
    Langstrom, Satu
    Koskenvuo, Minna
    Huttunen, Pasi
    Lassila, Riitta
    Taskinen, Mervi
    Ranta, Susanna
    Heikinheimo, Markku
    Makipernaa, Anne
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
  • [24] Complexity of Acute Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation at the Stage of the Occurrence and Risk Factors
    Lang, Tao
    Wang, Zengsheng
    Xu, Yanfang
    Wang, Yichun
    Li, Yan
    An, Li
    Mao, Min
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 68 - 68
  • [25] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Fu, Jianing
    Heinrichs, Jessica
    Yu, Xue-Zhong
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (04) : 277 - 301
  • [26] Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
    Choi, Sue In
    Lee, Eun Joo
    Kang, Dong Oh
    Lee, Sang Yeub
    In, Kwang Ho
    Kim, Han-Kyeom
    Park, Sanghoon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (06) : 1181 - 1183
  • [27] Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Pirotte, Michelle
    Forte, Florence
    Lutteri, Laurence
    Willems, Evelyne
    Duran, Unal
    Belle, Ludovic
    Baron, Frederic
    Beguin, Yves
    Maquet, Pierre
    Bodart, Olivier
    Servais, Sophie
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 323 : 115 - 118
  • [28] Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Li, Jian-Ming
    Giver, Cynthia R.
    Lu, Ying
    Hossain, Mohammad S.
    Akhtari, Mojtaba
    Waller, Edmund K.
    IMMUNOTHERAPY, 2009, 1 (04) : 599 - 621
  • [29] TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Yi Zhao
    Qiuyan Liu
    Li Yang
    Donghua He
    Lijuan Wang
    Jun Tian
    Yi Li
    Fuming Zi
    Hanying Bao
    Yang Yang
    Yuanyuan Zheng
    Jimin Shi
    Xingkui Xue
    Zhen Cai
    Cellular & Molecular Immunology, 2013, 10 : 165 - 175
  • [30] Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation
    Prenc, Ema
    Pulanic, Drazen
    Pucic-Bakovic, Maja
    Pezer, Marija
    Desnica, Lana
    Vrhovac, Radovan
    Nemet, Damir
    Pavletic, Steven Z.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (08): : 1615 - 1622